# Phase III Study Treatment of CLL B and C

> **NCT00535912** · PHASE3 · COMPLETED · sponsor: **French Innovative Leukemia Organisation** · enrollment: 140 (actual)

## Conditions studied

- Leukemia, Lymphocytic, Chronic

## Interventions

- **PROCEDURE:** Stem cells autograft

## Key facts

- **NCT ID:** NCT00535912
- **Lead sponsor:** French Innovative Leukemia Organisation
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1999-01
- **Primary completion:** —
- **Final completion:** 2006-03
- **Target enrollment:** 140 (ACTUAL)
- **Last updated:** 2007-11-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00535912

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00535912, "Phase III Study Treatment of CLL B and C". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00535912. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*